Enzo Biochem, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENZB research report →
About the company
Enzo Biochem, Inc. operates as an integrated entity encompassing diagnostics, clinical laboratory services, and life sciences. The company is dedicated to developing, manufacturing, and commercializing diagnostic and research products, fundamentally rooted in genetic engineering, biotechnology, and molecular biology.
- CEO
- Kara Cannon
- IPO
- 1980
- Employees
- 125
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $36.59M
- P/E
- -8.80
- P/S
- 2.66
- P/B
- 0.84
- EV/EBITDA
- -0.67
- Div Yield
- 0.00%
- Gross Margin
- 45.64%
- Op Margin
- -36.34%
- Net Margin
- -31.49%
- ROE
- -9.61%
- ROIC
- -10.52%
- Revenue
- $31.91M · 2.72%
- Net Income
- $-26,078,000 · -228.54%
- EPS
- $-0.51 · 59.84%
- Op Income
- $-9,817,000
- FCF YoY
- 32.54%
- 52W High
- $1.19
- 52W Low
- $0.25
- 50D MA
- $0.66
- 200D MA
- $0.63
- Beta
- 1.17
- Avg Volume
- 382.19K
Get TickerSpark's AI analysis on ENZB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 20, 25 | Radoff Bradley Louis | sell | 430,000 |
| Aug 20, 25 | PULLY STEVEN J | sell | 239,992 |
| Aug 20, 25 | Eckert Patricia | sell | 25,000 |
| Aug 20, 25 | Eckert Patricia | sell | 28,328 |
| Aug 20, 25 | COUCHMAN JONATHAN | sell | 277,237 |
| Aug 20, 25 | Cannon Kara | sell | 55,400 |
| Aug 20, 25 | Cannon Kara | sell | 45,065 |
| Jan 16, 25 | Radoff Bradley Louis | other | 142,897 |
| Jan 16, 25 | PULLY STEVEN J | other | 142,897 |
| Jan 16, 25 | COUCHMAN JONATHAN | other | 142,897 |
Our ENZB coverage
Recent articles, reports, and earnings notes.
No research on ENZB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ENZB report →Similar companies
Peers in the same neighborhood.